TO: Board of Supervisors
FROM: Sheryl L. Bratton, County Counsel
REPORT BY: Jason M. Dooley, Chief Deputy County Counsel
SUBJECT: Participation in the National Opioids Settlement with Sandoz, Inc., Purdue Pharma L.P. & Sackler Family, and several small generic pharmaceutical opioid manufacturers.
RECOMMENDATION
title
Authorize the Chief Executive Officer to execute documents necessary to participate in the National Opioids Settlements with multiple opioid manufacturer defendants, including: (1) Sandoz, Inc.; (2) Purdue Pharma L.P. & Sackler Family; and (3) Other several small generic pharmaceutical opioid manufacturers collectively. (Fiscal Impact: Increased Revenue; General Fund; Not Budgeted; Discretionary)
body
BACKGROUND
In May 2018, the Board authorized a consortium of outside counsel involved in the nationwide opioid litigation to file a federal complaint on behalf of the County against 14 manufacturers, distributors, and retailers of opioid drugs. In June 2018, the County joined with numerous other public entities across the state and nation in filing a federal complaint against opioid drug manufacturers, distributors, and retailers. In July 2021, the County entered into a set of settlement agreements with the opioid manufacturer Janssen Pharmaceuticals and its parent company, Johnson & Johnson and the three largest pharmaceutical distributors of opioids, entitling it to a share of statewide settlement funds. In March 2023, the County entered into similar settlement agreements with two pharmaceutical manufacturers, Teva and Allergan, and three pharmacies, CVS, Walgreens, and Walmart. In August 2024, the County entered into a settlement agreement with Kroger. Overall, from these settlements, the County is expected to receive approximately ten million dollars over 18 years, of which it received $951,605 at the close of FY 23-24. Since then, our office was notified by outside counsel of other opioid settlements that the County is eligible to participate ...
Click here for full text